Hologic Acquires Acessa To Add ProVu Fibroid Treatment

Hologic has agreed to pay $80m in cash, plus contingent payments for Acessa, a privately held developer of minimally invasive treatments for uterine fibroids.

MT2008_M-A_414545491_1200.jpg
• Source: shutterstock.com

Hologic Inc. is improving its gynecology surgery business by acquiring Acessa Health Inc. for $80m, the companies announced on 26 August.

Acessa Health markets the ProVu system, which integrates a handheld laparoscopic radiofrequency ablation tool with intra-abdominal ultrasound visualization and guidance mapping capabilities

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business